Elias Abdallah F, Stewart Philip E, Grimm Dorothee, Caimano Melissa J, Eggers Christian H, Tilly Kit, Bono James L, Akins Darrin R, Radolf Justin D, Schwan Tom G, Rosa Patricia
Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA.
Infect Immun. 2002 Apr;70(4):2139-50. doi: 10.1128/IAI.70.4.2139-2150.2002.
A major obstacle to studying the functions of particular gene products in the mouse-tick infectious cycle of Borrelia burgdorferi has been an inability to knock out genes in pathogenic strains. Here, we investigated conditions for site-directed mutagenesis in B31 MI, the low-passage-number, infectious B. burgdorferi strain whose genome was sequenced. We inactivated several plasmid and chromosomal genes in B31 MI and determined that clones carrying these mutations were not infectious for mice. However, we found extensive heterogeneity among clones and mutants derived from B31 MI based on colony phenotype, growth rate, plasmid content, protein profile, and transformability. Significantly, several B31 MI clones that were not subjected to mutagenesis but that lacked particular plasmids also exhibited defects at various stages in the infectious cycle. Therefore, the high degree of clonal polymorphism within B31 MI complicates the assessment of the contributions of individual genes to the observed phenotypes of the mutants. Our results indicate that B31 MI is not an appropriate strain background for genetic studies in infectious B. burgdorferi, and a well-defined isogenic clone is a prerequisite for targeted mutagenesis. To this end, we derived several wild-type clones from B31 MI that were infectious for mice, and gene inactivation was successful in one of these clones. Due to the instability of the genome with in vitro propagation, careful monitoring of plasmid content of derived mutants and complementation of inactivated genes will be crucial components of genetic studies with this pathogen.
在研究伯氏疏螺旋体在鼠蜱感染周期中特定基因产物的功能时,一个主要障碍是无法在致病菌株中敲除基因。在此,我们研究了在B31 MI中进行定点诱变的条件,B31 MI是低传代次数、具有感染性的伯氏疏螺旋体菌株,其基因组已被测序。我们使B31 MI中的几个质粒和染色体基因失活,并确定携带这些突变的克隆对小鼠没有感染性。然而,我们发现基于菌落表型、生长速率、质粒含量、蛋白质谱和转化能力,来自B31 MI的克隆和突变体之间存在广泛的异质性。值得注意的是,几个未进行诱变但缺乏特定质粒的B31 MI克隆在感染周期的各个阶段也表现出缺陷。因此,B31 MI内高度的克隆多态性使评估单个基因对突变体表型的贡献变得复杂。我们的结果表明,B31 MI不是用于感染性伯氏疏螺旋体遗传研究的合适菌株背景,明确的同基因克隆是定点诱变的先决条件。为此,我们从B31 MI中获得了几个对小鼠有感染性的野生型克隆,并且在其中一个克隆中基因失活成功。由于基因组在体外传代时的不稳定性,仔细监测衍生突变体的质粒含量以及对失活基因进行互补将是该病原体遗传研究的关键组成部分。